Published in Am J Cardiol on December 26, 2008
Predictors of atrial fibrillation following coronary artery bypass surgery. Med Sci Monit (2011) 1.67
Association of perioperative troponin and atrial fibrillation after coronary artery bypass grafting. Interact Cardiovasc Thorac Surg (2013) 0.89
De novo atrial fibrillation post cardiac surgery: the Durban experience. Cardiovasc J Afr (2015) 0.75
Comparison of Risk of Atrial Fibrillation in Black Versus White Patients After Coronary Artery Bypass Grafting. Am J Cardiol (2016) 0.75
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol (2006) 2.88
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology (2006) 2.63
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer. J Clin Oncol (2006) 2.27
Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res (2007) 2.19
Thinking outside the "box"-the ultrasound contrast controversy. J Am Coll Cardiol (2007) 2.06
Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation (2003) 2.03
Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr (2002) 1.98
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation (2012) 1.91
Echocardiographic indices do not reliably track changes in left-sided filling pressure in healthy subjects or patients with heart failure with preserved ejection fraction. Circ Cardiovasc Imaging (2011) 1.86
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol (2005) 1.61
A suggested roadmap for cardiovascular ultrasound research for the future. J Am Soc Echocardiogr (2011) 1.60
Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A (2006) 1.57
New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery. Ann Thorac Surg (2010) 1.55
Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol (2003) 1.54
New-onset postoperative atrial fibrillation after isolated coronary artery bypass graft surgery and long-term survival. Circ Cardiovasc Qual Outcomes (2009) 1.53
Established preoperative risk factors do not predict long-term survival in isolated coronary artery bypass grafting patients. Ann Thorac Surg (2012) 1.44
Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation. Am J Cardiol (2013) 1.43
Risk of not being discharged home after isolated coronary artery bypass graft operations. Ann Thorac Surg (2013) 1.40
Immediate open repair vs surveillance in patients with small abdominal aortic aneurysms: survival differences by aneurysm size. Mayo Clin Proc (2013) 1.39
Categorizing BMI may lead to biased results in studies investigating in-hospital mortality after isolated CABG. J Clin Epidemiol (2007) 1.26
Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol (2005) 1.23
DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol (2002) 1.22
Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol (2005) 1.19
Valvular heart disease: aortic regurgitation. Circulation (2005) 1.19
Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol (2003) 1.15
Tracheal resection in the morbidly obese patient: the role of dexmedetomidine. J Clin Anesth (2006) 1.10
Migration of an amplatzer septal occluder device for closure of atrial septal defect into the ascending aorta with formation of an aorta-to-right atrial fistula. Am J Cardiol (2005) 1.05
Mitral "annular" calcium forming a complete circle "O" causing mitral stenosis in association with a stenotic congenitally bicuspid aortic valve and severe coronary artery disease. Am J Geriatr Cardiol (2006) 0.96
Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography (2002) 0.96
Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST). Circulation (2003) 0.95
Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle (2012) 0.92
Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults. Am J Cardiol (2005) 0.90
A hospital-randomized controlled trial of an educational quality improvement intervention in rural and small community hospitals in Texas following implementation of information technology. Am J Med Qual (2007) 0.90
Non-invasive coronary angiography using multislice computed tomography. Heart (2005) 0.90
In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia (2015) 0.89
Grading severity of mitral regurgitation by echocardiography: science or art? JACC Cardiovasc Imaging (2010) 0.88
Initial experience in the treatment of thoracic aortic aneurysmal disease with a thoracic aortic endograft at Baylor University Medical Center. Proc (Bayl Univ Med Cent) (2008) 0.88
Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol (2013) 0.88
Obesity and stroke after cardiac surgery: the impact of grouping body mass index. Ann Thorac Surg (2007) 0.86
Surgical management of esophageal carcinoma. Proc (Bayl Univ Med Cent) (2003) 0.86
Preoperative visualization of a muscular ventricular septal defect by 64-slice cardiac computed tomography. Proc (Bayl Univ Med Cent) (2008) 0.85
Dramatic RV volume reduction following atrial septal defect closure demonstrated by multi-slice CT volume rendering. Clin Cardiol (2006) 0.85
Measurement of right ventricular volumes before and after atrial septal defect closure using multislice computed tomography. Am J Cardiol (2007) 0.85
Drug and gene delivery and enhancement of thrombolysis using ultrasound and microbubbles. Cardiol Clin (2004) 0.84
Advances in the assessment of no-reflow after successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: now that we can diagnose it, what do we do about it? J Am Coll Cardiol (2008) 0.84
Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. Circ Cardiovasc Imaging (2013) 0.83
Comparing long-term survival between patients undergoing off-pump and on-pump coronary artery bypass graft operations. Ann Thorac Surg (2011) 0.83
Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol (2004) 0.83
Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol (2013) 0.83
Islet purification method using large bottles effectively achieves high islet yield from pig pancreas. Cell Transplant (2012) 0.83
Effect of body mass index on risk of long-term mortality following coronary artery bypass grafting. Am J Cardiol (2006) 0.83
Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration). Am J Cardiol (2008) 0.82
Color flow imaging of the vena contracta in mitral regurgitation: technical considerations. J Am Soc Echocardiogr (2003) 0.82
Ischemic and functional mitral regurgitation in heart failure: natural history and treatment. Curr Cardiol Rep (2014) 0.82
Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol (2004) 0.81
Ultrasound contrast agents: balancing safety versus efficacy. Expert Opin Drug Saf (2009) 0.81
Clinical benefits of leukocyte filtration during valve surgery. Am J Surg (2003) 0.81
Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr (2010) 0.80
Modeling the effects of body mass index and waist-to-hip ratio on mortality. Eur J Epidemiol (2007) 0.80
Potential bioeffects of ultrasonic destruction of microbubble contrast agents. J Am Coll Cardiol (2006) 0.80
Effect of Optison on pulmonary artery systolic pressure and pulmonary vascular resistance. Am J Cardiol (2013) 0.80
Assessment of low-gradient aortic stenosis with dobutamine. Circulation (2006) 0.80
Imaging of low-gradient severe aortic stenosis. JACC Cardiovasc Imaging (2013) 0.79
Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). J Card Fail (2007) 0.79
Risk of death in heart disease is associated with elevated urinary globotriaosylceramide. J Am Heart Assoc (2014) 0.79
Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Am J Cardiol (2007) 0.79
Stress echo without the stress: detection of coronary stenosis at rest by myocardial contrast echocardiography. Circulation (2005) 0.79
A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging (2010) 0.79
Combined congenitally bicuspid aortic valve and mitral valve prolapse causing pure regurgitation. Proc (Bayl Univ Med Cent) (2013) 0.78
Improvement of collagenase distribution with the ductal preservation for human islet isolation. Islets (2012) 0.78
Improvement of porcine islet isolation by inhibition of trypsin activity during pancreas preservation and digestion using α1-antitrypsin. Cell Transplant (2012) 0.78
Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle (2012) 0.77
Mechanism and severity of mitral regurgitation by transesophageal echocardiography in patients referred for percutaneous valve repair. Am J Cardiol (2011) 0.77
Dobutamine challenge for low-gradient aortic stenosis. Circulation (2002) 0.77
Usefulness of serial brain natriuretic peptide measurements for managing aortic valve stenosis in pregnancy. Proc (Bayl Univ Med Cent) (2009) 0.75
New concepts in functional mitral regurgitation: it is not just a disease of the left ventricle. J Am Coll Cardiol (2013) 0.75
Congenital pulmonic stenosis in a 77-year-old woman successfully treated with percutaneous balloon valvuloplasty. Proc (Bayl Univ Med Cent) (2010) 0.75
Pacemaker laser lead extraction and reimplantation of dual-chamber implantable cardioverter defibrillator via Mustard baffle in complete transposition of great arteries. Proc (Bayl Univ Med Cent) (2010) 0.75
A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1. Hum Gene Ther Methods (2014) 0.75
The importance of regurgitant orifice shape in mitral regurgitation. JACC Cardiovasc Imaging (2011) 0.75
An effective purification method using large bottles for human pancreatic islet isolation. Islets (2012) 0.75
Reply: When to Call It Severe Mitral Regurgitation? J Am Coll Cardiol (2015) 0.75
Diagnosing cardiac sarcoidosis clinically without tissue confirmation. Proc (Bayl Univ Med Cent) (2009) 0.75